Newsroom | 4658 results

Sorted by: Latest

Radiology
-

Europe Stereotactic Neuro-Navigation System Market Report 2025-2035 | Opportunities Fueled by Integration of Artificial Intelligence (AI) and Machine Learning - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Stereotactic Neuro-Navigation System Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Europe stereotactic neuro-navigation system market is projected to reach $1.01 billion by 2035 from $269.0 million in 2024, growing at a CAGR of 13.14% during the forecast period 2025-2035. The market for stereotactic neuro-navigation systems in Europe is expected to develop significantly due to the rising demand for...
-

VideaHealth Named to TIME’s World’s Top HealthTech Companies 2025 List

BOSTON--(BUSINESS WIRE)--VideaHealth, the leader in AI-powered dental solutions, today announced its recognition on TIME’s inaugural list of the World’s Top HealthTech Companies 2025, in partnership with Statista. VideaHealth was recognized in the Diagnostics category with an Outstanding ranking, reflecting the company’s leadership in advancing AI-powered dental imaging and diagnostic accuracy. TIME’s list honors 400 companies from more than 25 countries across six categories, celebrating innov...
-

United States Radiology Information System Market Trends Report 2025-2033 | Cloud, AI Integration, and Rising Chronic Illnesses Drive Rapid Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Radiology Information System Market - Technology Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Radiology Information System Market is expected to reach US$ 636.55 million by 2033 from US$ 322.71 million in 2024, with a CAGR of 7.84% from 2025 to 2033. The region's market is driven by a number of factors, including the sophisticated healthcare infrastructure, widespread use of electronic heal...
-

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the launch of Oscar, an advanced training aid, introduced through its ENvue Medical (“ENvue” or “ENvue Medical”) division. Oscar is designed to provide clinicians and educators with a standardized, repeatable approach to practicing naso-enteral feeding procedures, addressing a key barrier to adoption of...
-

Vizient Announces 2025 Top Performers in Clinical Quality and Sustainability Excellence

IRVING, Texas--(BUSINESS WIRE)--The awards were announced Sept. 16 at the Vizient Connections Summit in Las Vegas....
-

Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced the expansion of its leadership team with four senior appointments, including Robert Kim, M.D., MBA as Chief Medical Officer, Daniel Elgort, Ph.D. as Chief Data & Analytics Officer, Josh Buddle as Head of Clinical Network and Longitudinal Research, and Jessamyn Wead as Head of People. The company also announced an expansion of its Seri...
-

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase and sale of 291,204 shares of its common stock (or common stock equivalents), at an offering price of $7.01 per share of common stock (or per common stock equivalent) in a registered direct offering pri...
-

Akumin Selected to Exhibit Akumin AXIS™ at Vizient Innovative Technology Exchange

PLANTATION, Fla.--(BUSINESS WIRE)--Akumin Inc. (“Akumin” or the “Company”), a leader in managed radiology and oncology services, has been selected to exhibit their proprietary Akumin AXIS Expandable Patient Solutions™ at the Vizient Innovative Technology Exchange®. Vizient®, the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange Sept. 17 in Las Vegas. The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to de...
-

Mevion Medical Systems Announces FDA Clearance for MEVION S250-FIT™ Proton Therapy System

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy.  The MEVION S250-FIT is the first and only proton therapy system designed to seamlessly fit into a standard radiation therapy vault. By leveraging existing infrastructure, the MEVION S250-FIT system lowers barrier...
-

Orano Med Achieves Key Milestone in French ATEF Facility Construction, an Essential Asset for Large-Scale Production of Innovative Lead-212-based Therapies

BESSINES-SUR-GARTEMPE, France--(BUSINESS WIRE)--Orano Med achieves key milestone in French ATEF facility construction, which has now reached the dry-in phase with sealing works completed....